RP @jtkidney.bsky.social: #ADVOCATE was not only an acronym but a prediction of who would deal with #Avacopan. Funding is needed to conduct studies that address dosing issues and new formulations intubated patients. Our patients need #advocates to fight…
#ADVOCATE was not only an acronym but a prediction of who would deal with #Avacopan. Funding is needed to conduct studies that address dosing issues and new formulations intubated patients. Our patients need #advocates to fight for treatment options of …
also note in main ADVOCATE there was a liver signal mentioned in text but not any of the tables www.nejm.org/doi/full/10.... too many concerns adding up - benefit small 3/4
Avacopan for the Treatment of ANCA-Associated Vasculitis. Avacopan is a C5a receptor inhibitor. Using it for the first time today!!! www.nejm.org/doi/full/10....